Bank Julius Baer & Co. Ltd, Zurich Coh Bar, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.96 - $1.62 $30,857 - $52,071	-32,143 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$1.09 - $1.49 $155 - $213	143 Added 0.45%	32,143 $45,000
Q1 2021 May 10, 2021	SELL	$1.26 - $2.02 $3,874 - $6,211	-3,075 Reduced 8.77%	32,000 $44,000
Q4 2020 Feb 24, 2021	BUY	$0.9 - $1.54 $31,275 - $53,515	34,750 Added 10692.31%	35,075 $47,000
Q4 2020 Feb 12, 2021	SELL	$0.9 - $1.54 $13,207 - $22,599	-14,675 Reduced 97.83%	325 $47,000
Q3 2020 Nov 10, 2020	BUY	$0.87 - $2.08 $13,050 - $31,200	15,000 New	15,000 $14,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.